162 related articles for article (PubMed ID: 24549600)
1. Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-κB ligand and selected adipose tissue hormones in girls with anorexia nervosa.
Ostrowska Z; Ziora K; Oświęcimska J; Świętochowska E; Marek B; Kajdaniuk D; Wołkowska-Pokrywa K; Kos-Kudła B
Endokrynol Pol; 2014; 65(1):33-9. PubMed ID: 24549600
[TBL] [Abstract][Full Text] [Related]
2. Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women.
Ostrowska Z; Świętochowska E; Marek B; Kajdaniuk D; Tyrpień-Golder K; Wołkowska-Pokrywa K; Damasiewicz-Bodzek A; Kos-Kudła B
Endokrynol Pol; 2014; 65(6):438-48. PubMed ID: 25554611
[TBL] [Abstract][Full Text] [Related]
3. Selected pro-inflammatory cytokines, bone metabolism, osteoprotegerin, and receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa.
Ostrowska Z; Ziora K; Oświęcimska J; Marek B; Świętochowska E; Kajdaniuk D; Strzelczyk J; Cieślicka A; Wołkowska-Pokrywa K; Kos-Kudła B
Endokrynol Pol; 2015; 66(4):313-21. PubMed ID: 26323468
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa.
Ostrowska Z; Ziora K; Oświęcimska J; Świętochowska E; Marek B; Kajdaniuk D; Strzelczyk J; Gołąbek K; Wołkowska-Pokrywa K; Kos-Kudła B
Endokrynol Pol; 2016; 67(5):493-500. PubMed ID: 27828689
[TBL] [Abstract][Full Text] [Related]
5. RANKL/RANK/OPG system and bone status in females with anorexia nervosa.
Ostrowska Z; Ziora K; Oświęcimska J; Swiętochowska E; Szapska B; Wołkowska-Pokrywa K; Dyduch A
Bone; 2012 Jan; 50(1):156-60. PubMed ID: 22001124
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa.
Ostrowska Z; Ziora K; Oświęcimska J; Wołkowska-Pokrywa K; Szapska B
Postepy Hig Med Dosw (Online); 2013 May; 67():433-41. PubMed ID: 23752595
[TBL] [Abstract][Full Text] [Related]
7. Association between omentin-1, bone metabolism markers, and cytokines of the RANKL/RANK/OPG system in girls with anorexia nervosa.
Gołąbek K; Ostrowska Z; Ziora K; Oświęcimska J; Świętochowska E; Marek B; Kajdaniuk D; Strzelczyk J; Kos-Kudła B
Endokrynol Pol; 2015; 66(6):514-20. PubMed ID: 26662650
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa.
Ostrowska Z; Ziora K; Oświęcimska J; Swiętochowska E; Wołkowska-Pokrywa K
Postepy Hig Med Dosw (Online); 2012 Sep; 66():655-62. PubMed ID: 23001207
[TBL] [Abstract][Full Text] [Related]
9. Vaspin and selected indices of bone status in girls with anorexia nervosa.
Ostrowska Z; Ziora K; Oświęcimska J; Świętochowska E; Marek B; Kajdaniuk D; Strzelczyk J; Gołąbek K; Morawiecka-Pietrzak M; Wołkowska-Pokrywa K; Kos-Kudła B
Endokrynol Pol; 2016; 67(6):599-606. PubMed ID: 28042653
[TBL] [Abstract][Full Text] [Related]
10. Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women.
Ostrowska Z; Kos-Kudła B; Marek B; Kajdaniuk D; Wołkowska-Pokrywa K
Postepy Hig Med Dosw (Online); 2011 Oct; 65():658-67. PubMed ID: 22100799
[TBL] [Abstract][Full Text] [Related]
11. Melatonin, the RANKL/RANK/OPG system, and bone metabolism in girls with anorexia nervosa.
Ostrowska Z; Ziora K; Kos-Kudła B; Swietochowska E; Oświecimska J; Dyduch A; Wołkowska-Pokrywa K; Szapska B
Endokrynol Pol; 2010; 61(1):117-23. PubMed ID: 20205114
[TBL] [Abstract][Full Text] [Related]
12. The relationship between chemerin, bone metabolism, the RANKL/RANK/OPG system, and bone mineral density in girls with anorexia nervosa.
Ostrowska Z; Morawiecka-Pietrzak M; Pluskiewicz W; Świętochowska E; Strzelczyk J; Gołąbek K; Gaździcka J; Ziora K
Endokrynol Pol; 2022; 73(1):26-34. PubMed ID: 35119086
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin and receptor activator of the nuclear factor kappa B ligand (RANKL) in healthy pubertal girls - relationships with physical growth and classical bone turnover markers.
Kulik-Rechberger B; Kozłowska M
J Physiol Pharmacol; 2024 Feb; 75(1):. PubMed ID: 38583439
[TBL] [Abstract][Full Text] [Related]
14. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
15. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
Mountzios G; Dimopoulos MA; Bamias A; Papadopoulos G; Kastritis E; Syrigos K; Pavlakis G; Terpos E
Acta Oncol; 2007; 46(2):221-9. PubMed ID: 17453373
[TBL] [Abstract][Full Text] [Related]
16. Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients.
Carmona-Fernandes D; Santos MJ; Perpétuo IP; Fonseca JE; Canhão H
Arthritis Res Ther; 2011; 13(5):R175. PubMed ID: 22027240
[TBL] [Abstract][Full Text] [Related]
17. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
[TBL] [Abstract][Full Text] [Related]
18. Circulating osteoprotegerin and soluble RANK ligand in systemic sclerosis.
Dovio A; Data V; Carignola R; Calzolari G; Vitetta R; Ventura M; Saba L; Severino A; Angeli A
J Rheumatol; 2008 Nov; 35(11):2206-13. PubMed ID: 18843778
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats.
Brzóska MM; Rogalska J
Toxicol Appl Pharmacol; 2013 Oct; 272(1):208-20. PubMed ID: 23726800
[TBL] [Abstract][Full Text] [Related]
20. sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients.
Doumouchtsis KK; Kostakis AI; Doumouchtsis SK; Tziamalis MP; Tsigris C; Kostaki MA; Perrea DN
J Endocrinol Invest; 2007 Oct; 30(9):762-6. PubMed ID: 17993768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
